The influence of established and new antiepileptic drugs on visual perception. 1. A placebo-controlled, double-blind, single-dose study in healthy volunteers

By Steinhoff B.J.   Freudenthaler N.   Paulus W.  

Epilepsy Research, Vol. 29, Iss. 1, 1997-12 ,pp. : 35-47

Elsevier

Access to resources Recommend Favorite

A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis

By Collin C.   Ehler E.   Waberzinek G.   Alsindi Z.   Davies P.   Powell K.   Notcutt W.   O'Leary C.   Ratcliffe S.   Nováková I.   Zapletalova O.   Piková J.   Ambler Z.  

Neurological Research, Vol. 32, Iss. 5, 2010-06 ,pp. : 451-459

Maney Publishing

Access to resources Recommend Favorite

Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy

By Sharief M.   Viteri C.   Ben-Menachem E.   Weber M.   Reife R.   Pledger G.   Karim R.  

Epilepsy Research, Vol. 25, Iss. 3, 1996-11 ,pp. : 217-224

Elsevier

Access to resources Recommend Favorite

Treatment of spasticity with repetitive magnetic stimulation; a double-blind placebo-controlled study

By Nielsen J.F.   Sinkjaelig r T.   Jakobsen J.  

Electroencephalography and Clinical Neurophysiology/ Electromyography and Motor Control, Vol. 97, Iss. 4, 1995-09 ,pp. : 142-142

Elsevier

Access to resources Recommend Favorite

A Double-Blind Study of Paroxetine, Fluoxetine, and Placebo an Outpatients with Major Depression

By Fava M.  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 10, Iss. 4, 1998-12 ,pp. : 145-150

Springer Publishing Company

Access to resources Recommend Favorite